Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 18,190 shares at $28.79 ($524K) on 2024-10-16, disclosed to the SEC on 2024-10-18.
Open-market sale of $524k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.79 | 9,095 | $262K | 50.0% |
| 2 | $28.79 | 9,095 | $262K | 50.0% |
| Total | $28.79 avg | 18,190 | $524K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |